Lauren Julia Brown (Lauren Brown, Lauren J Brown)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Liver Metastases

Endoplasmic Reticulum

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Cancer medicine

Pharmaceuticals (Basel, Switzerland)

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren Julia Brown, Julie Ahn, Bo Gao, Harriet Gee, Adnan Nagrial, Eric Hau, Inês Pires da Silva
Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy. Cancers 16 (11) (2024)
Lauren Julia Brown, Julie Ahn, Bo Gao, Harriet Gee, Adnan Nagrial, Eric Hau, Inês Pires da Silva
Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy. Cancers 16 (11) (2024)
Lauren Julia Brown, Ines Pires da Silva, Tania Moujaber, Bo Gao, Rina Hui, Howard Gurney, Matteo Carlino, Adnan Nagrial
Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres. Cancer medicine (2022)
Lauren Julia Brown, Joanna Achinger-Kawecka, Neil Portman, Susan Clark, Clare Stirzaker, Elgene Lim
Epigenetic Therapies and Biomarkers in Breast Cancer. Cancers 14 (3) (2022)
Lauren Julia Brown, Alison Weppler, Prachi Bhave, Clara Allayous, J Randall Patrinely, Patrick Ott, Shahneen Sandhu, Andrew Haydon, Celeste Lebbe, Douglas B Johnson, Georgina V Long, Alexander A Menzies, Matteo S Carlino
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders. Journal for immunotherapy of cancer 9 (5) (2022)
Keith Wong, Gemma Sheehan-Dare, Andrew Nguyen, Bao Ho, Victor Liu, Jonathan Lee, Lauren Julia Brown, Rachel Dear, Lyn Chan, Shikha Sharma, Alessandra Malaroda, Isabelle Smith, Elgene Lim, Louise Emmett
64 Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)